Abbott RealTime IDH1
U.S. real-time PCR assay for source-scoped IDH1 mutation testing in AML and myeloid malignancy treatment-selection contexts.
- Developer
- Abbott Molecular
- Intended use
- Other
- Cancer scope
- Acute myeloid leukemia, Myeloid malignancies
- Specimen
- Bone marrow aspirate, Whole blood
- Molecular modality
- DNA mutation
- Current version
- Current Abbott RealTime IDH1 REF 08N90-090, package-insert revision R4; five IDH1 R132 mutations
- Evidence context
- 0 structured studies · 0 indexed performance results · 1 sources
Why can reported performance numbers differ? MDI keeps each result attached to its study, population, stage or stratum, test version and source rather than treating performance as a fixed property of the test.